Insulin receptor and ageing

Pathologie Biologie

Volumn 51, Issue 10, 2003, Pages 574-580

  Fulop, Tamas ^a   Larbi, Anis ^a   Douziech, Nadine ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Ageing; Insulin receptor; Insulin receptor substrate; Insulin resistance; Signal transduction

Indexed keywords

GLUCOSE TRANSPORTER; INSULIN; INSULIN RECEPTOR;

AGE; AGING; ENVIRONMENT; GERIATRIC DISORDER; GERIATRIC PATIENT; GLUCOSE BLOOD LEVEL; HORMONE ACTION; HUMAN; INSULIN RESISTANCE; LONGEVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHYSIOLOGY; PROTEIN FUNCTION; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0344413421     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2003.09.007     Document Type: Article

References (53)

1. Halter JB. Diabetes mellitus. In: Hazzard WR, Blass JP, Ettinger WH, Halter JB, Ouslander JG, editors. Principles of geriatric medicine and gerontology. New york: McGraw Hill 1999; p. 991-1012.
2. Gerich JE. Contributions of insulin-resistance and insulin secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clinic Proc 2003;78:447-56.
3. Alper J. Biomedicine: new insights into type 2 diabetes. Science 2000;289:37-9.
4. Khan AH, Pessin JE. Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways. Diabetologia 2002;45:1475-83.
5. Jonsaton AM, Pirola L, Van Obberghen E. Molecular mechanisms of insulin receptor substrate protein-mediated modulation of insulin signalling. FEBS Lett 2003;546:32-6.
6. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2000;103:211-25.
7. Myers Jr MG, Sun XJ, Whyte MF. The IRS-1 signaling system. Trends Biochem Sci 1994;19:289-93.
8. Paz K, Hemi R, LeRoith D, Karasik A, Elhanany E, Kanethy H, et al. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem 1997;272:29911-8.
9. Greene MW, Carofalo RS. Positive and negative regulatory role of insulin receptor substrate 1 and 2 (IRS-1 and IRS-2) serine/threonine phosphorylation. Biochemistry 2002;41:7082-91.
10. Cheng A, Dubé N, Gu F, Tremblay ML. Coordinated action of protein tyrosine phosphatases in insulin signal transduction. Eur J Biochem 2002;269:1050-9.
11. Nystrom FH, Quon MJ. Insuilin signalling; metabolic pathways and mechanisms for specificity. Cell Signal 1999;11:563-74.
12. Cong LN, Chen H, Li Y, Zhu L, McGibbon MA, Taylor SI, et al. Physiological role of Akt in insulin stimulated translocation of GLUT4 in transfected rat adipose cells. Mol Endocrinol 1997;11:1881-90.
13. Zeng G, Nystrom FH, Ravichandran RV, Cong LN, Kirby M, Mostowski H, et al. Roles of insulin receptor, PI3Kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 2000;101:1539-45.
14. Iida KT, Suzuki H, Sone H, Shimano H, Toyoshima H, Yatoh S, et al. Insulin inhibits apoptosis of macrophage cell line, THP-1 cells, via phosphatidylinositol-3-kinase dependent pathway. Arterioscler Thromb Vasc Biol 2002;22:380-6.
15. Chiang SH, Baumann CA, Kanzaki M, Thurmond DC, Watson RT, Naudaurer CL, et al. Insulin stimulated GLUT4 translocation requires the CAP dependent activation of TC10. Nature 2001;410:944-8.
16. Baumann CA, Ribon V, Kanzaki M, Thurmond DC, Mora S, Shigematsu S, et al. CAP defines a second signalling pathway required for insulin stimulated glucose transport. Nature 2000;407:202-7.
17. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997;387:569-75.
18. Silvius JR. Role of cholesterol in lipid raft formation: lessons from lipid model systems. Biochim Biophys Acta 2003;1610:174-83.
19. Vaino S, Heino S, Mansson JE, Fredman P, Kuismanen E, Vaarala O, et al. Dynamic association of human insulin receptor with lipid rafts in cells lacking caveolae. EMBO Rep 2002;3:95-100.
20. Murray TM, Deesay KS, Cinader B. Age-related changes in hepatic and splenic insulin receptors and serum insulin and glucose levels in inbred mice. Metabolism 1993;42:140-4.
21. Wang ZQ, Bell-Farrow AD, Sonntag W, Cefalu WT. Effect of age and caloric restriction on insulin receptor binding and glucose transporter levels in aging rat. Exp Ger 1997;32:671-84.
22. Torlinska T, Mackowiak P, Nogowski L, Hryniewcki T, Witmanowski H, Perz M, et al. Age-dependent changes of insulin receptor in rat tissues. J Physiol Pharmacol 2000;51:871-81.
23. Fulop Jr T, Nagy J, Worum I, Foris G, Mudri K, Udvardy M. Glucose intolerance and insulin resistance with aging. Studies on insulin receptors and post-receptor events. Arch Gerontol Geriatr 1987;6:107-15.
24. Zaia A, Piantanelli L. Insulin receptors in the brain cortex of aging mice. Mech Age Dev 2000;113:227-32.
25. Martineau LC, Chadan SG, Parkhouse WS. Age associated alterations in cardiac and skeletal muscle glucose transporters, insulin and IGF-1 receptors and PI3-kinase protein contents in the C57BL/6 mouse. Mech Age Dev 1999;106:217-32.
26. Kono S, Kuzuya H, Okamoto M, Nishimura H, Kosaki A, Kakahi T, et al. Changes in insulin receptor kinase with aging in rat skeletal muscle and liver. Am J Physiol 1990;259:27-35.
27. Carvalho CR, Brenelli SL, Silva AC, Nunez AI, Velloso LA, Staad MJ. Effect of aging on insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle rats. Endocrinology 1996;137:151-9.
28. Reed MJ, Reaven GM, Mondoe CE, Azhar S. Why does insulin resistance develop during maturation. J Gerontol 1993;48:139-44.
29. Molero JC, Perez C, Martinez C, Villar M, Andres A, Fermin Y, et al. Activation of MAP kinase by insulin and vanadate in adipocytes from young and old rats. Mol Cell Endocrinol 2002;189:77-84.
30. Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Patipanawatr T, et al. Insulin resistance differentially affects the PI3-kinase and MAPK mediated signalling in human muscle. J Clin Invest 2000;105:597-611.
31. Frolich L, Blum-Degen D, Bernstein H-G, Engelsberger S, Humrich J, Laufer S, et al. Brain insulin receptors in aging and sporadic Alzheimer's disease. J Neurol Transm 1998;105:423-38.
32. Hoyer S. The aging brain. Changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review. J Neurol Transm 2002;109:991-1002.
33. Baskin DG, Wilcox BJ, Figlewicz DP, Dorsa DM. Insulin and insulin like growth factors in the CNS. Trends Neurosci 1988;11:107-11.
34. Kremerskothen J, Wendholt D, Teber I, Barnekow A. Insulin induced expression of the activity regulated cytoskeleton associated gene (ARC) in human neuroblastoma cells requires p21ras mitogen activated protein kinase/extracellular regulated kinase and src tyrosine kinases but is protein kinase C-independent. Neurosci Lett 2002;321:153-6.
35. Conejo R, Lorenzo M. Insulin signalling leading to proliferation, survival and membrane ruffling in C2C12 myoblasts. J Cell Physiol 2001;187:96-108.
36. Facchini FS, Hua NW, Reaven GM, Stoohs RA. Hyperinsulinemia: the missing link among oxidative stress and age-related diseases? Free Radic Biol Med 2000;29:1302-6.
37. Brownlee M. Negative consequences of glycation. Metabolism 2000;49:9-13.
38. Kimura T, Takamatsu J, Ikeda K, Kondo A, Miyakawa T, Horiuchi S. Accumulation of advanced glycation end products of the Maillard reaction with age in human hippocampal neurons. Neurosci Lett 1996;208:53-6.
39. Wautier JL, Wautier MP, Schmidt AM, Anderson GM, Hori O, Zoukourian C, et al. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface associated AGEs and diabetic complications. Proc Natl Acad Sci USA 1994;91:7742-6.
40. Wolff SP, Jianng ZY, Hunt JV. Protein glycation and oxidative stress in diabetes mellitus and aging. Free Radic Biol Med 1991;10:339-52.
41. Harman D. Ageing: a theory based on free radical and radiation chemistry. J Gerontol 1956;11:145-7.
42. Tessier D, Khalil A, Fülöp Jr T. Effect of oral glucose challenge on free radicals/antioxidant balance in an older population with non insulin dependent diabetes mellitus (NIDDM). J Gerontol 1999;54A: M541-5.
43. Eklund J, Bradford GE. Longevity and lifetime body weight in mice selected for rapid growth. Nature 1977;265:48-9.
44. McCulloch D, Gems D. Body size, insulin/IGF signalling and aging in the nematode Caenorhabditis elegans. Exp Ger 2003;38:129-36.
45. Murakami S, Johnson TE. A genetic pathway conferring life extension and resistance to UV stress in Caenorhabditis elegans. Genetics 1996;143:1207-18.
46. Hekimi S, Benard C, Branicky R, Burgess J, Hihi AK, Rea S. Why only time will tell. Mech Age Dev 2001;122:571-94.
47. Deprès JP, Lamarche B, Marioge B. Hyperinsulinemia is an independent risk factor for ischemic heart disease. New Engl J Med 1996;334:952-7.
48. Krentz AJ, Nattrass M. Insulin resistance; a multifaceted metabolic syndrome. Insights gained using low-dose insulin infusion technique. Diabetes Med 1996;13:30-9.
49. Paolisso G, Garnbardella A, Ammendola S. Glucose tolerance and insulin action in healthy centenarians. Am J Physiol 1996;270:E890-4.
50. Masoro EJ, Shimokawa I, Yu BP. Retardation of the aging processes in rats by food restriction. Ann NY Acad Sci 1991;621:337-52.
51. Pawelec G, Hirokawa K, Fulop T. T cell signaling with aging. Mech Age Dev 2001;122:1613-37.
52. Zs-Nagy I, Kitani K, Ohta M, Zs-Nagy V, Imahori K. Age-dependent decrease of the lateral diffusion constant of proteins in the plasma membrane of hepatocytes as revealed by fluorescent recovery after photobleaching in tissue smears. Arch Gerontol Geriatr 1986;5:131-41.
53. Fülöp Jr T, Douziech N, Goulet AC, Desgeorges S, Linteau A, Lacombe G, et al. Cyclodextrin modulation of T lymphocyte signal transduction with aging. Mech Age Dev 2001;122:1413-31.